Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.48 |
| ▸ | VNN1 | O95497 | 12/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22191048 | 0.87 | VNN1 (0.55) | DYRK1AVNN1LRRK2 | |
| SCHEMBL22191481 | 0.84 | VNN1 (0.48) | DYRK1AVNN1KDM4EGAAPDE3B | |
| SCHEMBL22190998 | 0.84 | GAA (0.47) | DYRK1AVNN1KDM4EALDH1A1GAA | |
| SCHEMBL28644765 | 0.84 | PLK4 (0.55) | VNN1KDM4EGAAPDE3BPDE3A | |
| SCHEMBL22191095 | 0.84 | PLK4 (0.50) | DYRK1AVNN1GAAPDE3BPDE3A | |
| SCHEMBL22191749 | 0.83 | LRRK2 (0.47) | DYRK1AKDM4EALDH1A1GAALRRK2 | |
| SCHEMBL22191347 | 0.83 | PDE3B (0.60) | DYRK1AVNN1KDM4EGAAPDE3B | |
| SCHEMBL22191100 | 0.81 | VNN1 (0.51) | VNN1KDM4EALDH1A1GAAHPGD | |
| SCHEMBL22191453 | 0.80 | VNN1 (0.52) | DYRK1AVNN1PDE3BPDE3A | |
| SCHEMBL22191518 | 0.79 | PDE3B (0.45) | KDM4EGAAPDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3906028-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | Icahn School of Medicine at Mount Sinai (US) | 2021-11-10 | — | — | EP | disclosed |
| CN-113543783-A | Kinase inhibitor compounds and compositions and methods of use | 西奈山伊坎医学院 | 2021-10-22 | — | — | CN | disclosed |
| WO-2020142486-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2020-07-09 | — | — | WO | disclosed |